Tag Archives: Adaptive Biotechnologies

Genentech, Adaptive Bio Join Forces on Personalized Cancer Drugs R&D

Genentech is paying Adaptive Biotechnologies $300 million up front in a new partnership focused on developing cancer immunotherapies personalized to individual patients. Seattle-based Adaptive has technology that can analyze the immune system to find targets for cell therapies. Adaptive says that its screening technology enables it to discover T-cell receptors (TCRs) that can recognize and […]

What’s Hot in Seattle Biotech: Tech, Life Sciences Convergence & More

Like a good cup of coffee, Seattle’s life sciences ecosystem is a balanced blend of complementary parts: research to find the underpinnings of disease, and information technology that helps scientists make sense of the data. That convergence was on display last week at Xconomy’s annual What’s Hot in Seattle Biotech event. Here are a few […]

Posted in National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Allen Institute for Brain Science, Alzheimer's disease, ARCH Venture Partners, big data, BioCrossroads, Biotech, Blaze Bioscience, Cambia Grove, cancer, Claudia Mitchell, EpiThany, Harlan Robins, Icon, investing, IT, Ivan Liachko, KenSci, Leen Kawas, Life Sciences, M3 Biotechnology, Microsoft, Nicholas Mark, people, Phase Genomics, SEngine Precision Medicine, Software, startups, Universal Cells, VC, Venture Capital, xconSEAbiotech2018 | Comments Off

Last Chance to Save on What’s Hot in Seattle Biotech

There’s just one week left before Xconomy’s latest biotech event, “What’s Hot in Seattle Biotech.” Don’t let the clock run out while you can still save some cash on a ticket. Next Tuesday, June 12, we’re bringing together some of the Emerald City’s top life science entrepreneurs, scientists, and investors to discuss the strengths and […]

Posted in National, National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Allen Institute for Brain Science, Amy Bernard, Bill and Melinda Gates Foundation, Bill Watt, Blaze Bioscience, Cambia Grove, Claudia Mitchell, Dan Wattendorf, Desney Tan, EpiThany, Harlan Robins, Heather Franklin, Impel NeuroPharma, Ivan Liachko, Jon Congleton, KenSci, Lara Mangravite, Leen Kawa, Life Sciences, M3 Biotechnology, Maura Little, Microsoft Research, Nicholas Mark, Peter Thompson, Phase Genomics, Sage Bionetworks, SEngine Precision Medicine, Silverback Therapeutics, startups, Universal Cells, VK Gadi, xconSEAbiotech2018 | Comments Off

What’s Hot in Seattle Biotech: Here’s the Agenda for the June 12 Event

Seattle’s innovation economy has dual identities: the technology sector that develops the hardware and software that comprise our increasingly digital lives, and the biotechnology sector that is searching for new ways to treat disease. The convergence of those fields makes the Puget Sound region a hotbed of activity. We will take a look at some […]

Posted in National blog main, National top stories, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Air Force Medical Genetics Center, Allen Institute for Brain Science, Amy Bernard, Bill & Melinda Gates Foundation, Biotech, cancer, Claudia Mitchell, Dan Wattendorf, Defense Advanced Research Projects Agency, Desney Tan, Eric Dobmeier, Harlan Robins, Impel NeuroPharma, IT, Ivan Liachko, Jon Congleton, KenSci, Lara Mangravite, Leen Kawas, Life Sciences, M3 Biotechnology, Microsoft, Nicholas Mark, Phase Genomics, Sage Bionetworks, Silverback Therapeutics, Software, startups, Universal Cells, Walter Reed National Military Medical Center, xconSEAbiotech2018 | Comments Off

Grab the Early Bird Rate for What’s Hot in Seattle Biotech on June 12

Leaders from the life sciences industry are coming together for Xconomy’s special event on Seattle biotech on June 12 at Cambia Grove. Act now to get the best price on tickets for what we expect will be a sold-out event! Join us to hear from the Emerald City’s top life science entrepreneurs, scientists, investors, and […]

Posted in National, National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Claudia Mitchell, Desney Tan, Eric Dobmeier, Harlan Robins, Leen Kawa, Life Sciences, M3 Biotechnology, Microsoft Research, Silverback Therapeutics, startups, Universal Cells, xconSEAbiotech2018 | Comments Off

Get the Inside Scoop on Seattle Life Sciences at Xconomy’s June Event

Xconomy’s annual Seattle-area life sciences conference will be held on June 12 at Cambia Grove in the Emerald City’s downtown. “What’s Hot in Seattle Biotech” will look at what’s hot, and what’s next, for the Puget Sound region’s life sciences scene. It’s only March , but already this year, Seattle’s life science community has seen […]

Posted in National, National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Eric Dobmeier, Harlan Robins, Leen Kawa, Life Sciences, M3 Biotechnology, Silverback Therapeutics, startups, xconSEAbiotech2018 | Comments Off

Last Chance to Save on “Healthcare + A.I. Northwest”

We are just a week away from “Healthcare + A.I. Northwest” —and we’re offering you a chance to save $80. Join us for an afternoon of keynote talks, fireside chats, and panel discussions that will delve into how artificial intelligence may transform healthcare. It all takes place the afternoon of Thursday, Nov. 9, at Cambia […]

Posted in National, National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged Accolade, Adaptive Biotechnologies, Alice Zhang, Allen Institute for Artificial Intelligence, angelMD, Cambia Grove, CuraCloud, Cybersecurity, Cyrus biotechnology, Ed Butler, EigenHealth, Evgeni Sokurenko, Fred Hutchinson Cancer Research Center, Harjinder Sandhu, ID Genomics, Ivor Horn, Jens Francis, Kirsten Morbeck, Lucas Nivon, Lynn McGrath Jr., Mary Haggard, Matthew Thompson, Maura Little, Microsoft Research, Mike McSherry, Mike Van Snellenberg, Oren Etzioni, Peter Lee, Peter Neupert, Product Creation Studio, Providence, SayKara, Scott Thielman, Shelly Fritz, Soheil Meshinchi, SpringRock Ventures, University of Washington, Verge Genomics, Washington State University College of Nursing, Wellpepper, Xealth | Comments Off

Last Chance for “What’s Hot in Cancer Immunotherapy 2017” Tickets

Registration is closing soon for Xconomy’s “What’s Hot in Cancer Immunotherapy 2017.” It’s all happening on Wednesday, June 14, at the Fred Hutchinson Cancer Research Center in Seattle. We have lined up some of the most forward-thinking entrepreneurs, investors, and innovators in cancer immunotherapy. Join us for an afternoon of spotlight talks, chats, and panel […]

Posted in Boston blog main, National, National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Alpine Immune Sciences, Andrew Allen, Brad Gray, Cancer Research Institute, Chad Robins, Eli Lilly and Company, Fred Hutchinson Cancer Research Center, Gritstone Oncology, Hans Bishop, Jill O'Donnell-Tormey, Juno Therapeutics, Life Sciences, Lion Biotechnologies, Maria Fardis, Michael Jensen, Michael Kalos, Mitch Gold, Nanostring Technologies, Phil Greenberg, Renato Martins, Seattle Children's Research Institute, startups, Sylvia Lee, Tech, University of Washington, University of Washington School of Medicine | Comments Off

Grab Your Ticket for What’s Hot in Cancer Immunotherapy 2017 on June 14th

We are just a week away from “What’s Hot in Cancer Immunotherapy 2017”—and we’re offering you a chance to save $100. Join us for an afternoon of spotlight talks, fireside chats, and panel discussions that will delve into a variety of cancer immunotherapy topics. It all takes place on Wednesday, June 14, at Fred Hutchinson […]

Posted in National, National blog main, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Alpine Immune Sciences, Andrew Allen, Brad Gray, Cancer Research Institute, Chad Robins, Eli Lilly and Company, Fred Hutchinson Cancer Research Center, Gritstone Oncology, Hans Bishop, Jill O'Donnell-Tormey, Juno Therapeutics, Life Sciences, Lion Biotechnologies, Maria Fardis, Michael Jensen, Michael Kalos, Mitch Gold, Nanostring Technologies, Phil Greenberg, Renato Martins, Seattle Children's Research Institute, startups, Sylvia Lee, Tech, University of Washington, University of Washington School of Medicine | Comments Off

Check Out The Agenda for What’s Hot in Cancer Immunotherapy 2017

We have posted the agenda for What’s Hot in Cancer Immunotherapy 2017, which is taking place on June 14 at the Fred Hutchinson Cancer Research Center in Seattle. Xconomy is gathering some of the field’s experts to assess the past and future opportunities and challenges when using the immune system to fight cancer—folks like Hans […]

Posted in National, National blog main, National top stories, Seattle, Seattle blog main, Seattle top stories | Tagged Adaptive Biotechnologies, Alpine Immune Sciences, Andrew Allen, Brad Gray, Cancer Research Institute, Chad Robins, Fred Hutchinson Cancer Research Center, Gritstone Oncology, Hans Bishop, Jill O'Donnell-Tormey, Juno Therapeutics, Life Sciences, Lion Biotechnologies, Maria Fardis, Michael Jensen, Mitch Gold, Nanostring Technologies, Phil Greenberg, Renato Martins, Seattle Children's Research Institute, startups, Sylvia Lee, Tech, University of Washington, University of Washington School of Medicine | Comments Off← Older posts Newer posts →

Tag Archives: Adaptive Biotechnologies

Archives

Meta